PL2374461T3 - Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką - Google Patents
Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczkąInfo
- Publication number
- PL2374461T3 PL2374461T3 PL11001816T PL11001816T PL2374461T3 PL 2374461 T3 PL2374461 T3 PL 2374461T3 PL 11001816 T PL11001816 T PL 11001816T PL 11001816 T PL11001816 T PL 11001816T PL 2374461 T3 PL2374461 T3 PL 2374461T3
- Authority
- PL
- Poland
- Prior art keywords
- piroxicam
- prophylactic
- therapeutic treatment
- herpes infections
- herpes
- Prior art date
Links
- 206010019973 Herpes virus infection Diseases 0.000 title 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 title 1
- 229960002702 piroxicam Drugs 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010014290A DE102010014290A1 (de) | 2010-04-08 | 2010-04-08 | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
| EP11001816.5A EP2374461B1 (fr) | 2010-04-08 | 2011-03-04 | Piroxicam pour traitement prophylactique et thérapeutique d'infections de type Herpès |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2374461T3 true PL2374461T3 (pl) | 2017-08-31 |
Family
ID=43970974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11001816T PL2374461T3 (pl) | 2010-04-08 | 2011-03-04 | Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130190301A1 (fr) |
| EP (1) | EP2374461B1 (fr) |
| JP (1) | JP6158077B6 (fr) |
| CN (1) | CN103153312B (fr) |
| CA (1) | CA2795334C (fr) |
| DE (1) | DE102010014290A1 (fr) |
| DK (1) | DK2374461T3 (fr) |
| ES (1) | ES2612584T3 (fr) |
| PL (1) | PL2374461T3 (fr) |
| RU (1) | RU2555765C2 (fr) |
| WO (1) | WO2011124366A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010014290A1 (de) * | 2010-04-08 | 2011-10-13 | Hans Otto Meyer zu Spelbrink | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
| DE102013003756A1 (de) | 2013-03-06 | 2014-09-11 | DeaValorum UG (haftungsbeschränkt) | Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen |
| DE102013014787A1 (de) | 2013-09-09 | 2015-03-12 | Dauphine UG (haftungsbeschränkt) | Mittel zur prophylaktischen und therapeutischen Behandlung von EHV-Infektionen |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
| IT1216686B (it) * | 1988-04-01 | 1990-03-08 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione. |
| IT1230922B (it) * | 1989-06-23 | 1991-11-08 | Giuseppe De Benedittis | Composizione per il trattamento della nevralgia erpetica acuta e della nevralgia post erpetica |
| DK0453603T3 (da) * | 1990-04-26 | 1993-11-22 | Com Pharm Arzneimittel Gmbh | Piroxicamholdige farmaceutiske præparater til topisk anvendelse |
| JP3031990B2 (ja) * | 1990-10-19 | 2000-04-10 | 同仁医薬化工株式会社 | 消炎鎮痛クリーム剤組成物 |
| RU2182016C2 (ru) * | 1997-03-20 | 2002-05-10 | Панацея Биотек Лтд. | Спазмолитическая композиция, способ получения спазмолитической композиции |
| DE10300222A1 (de) * | 2003-01-03 | 2004-07-15 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| DE102010014290A1 (de) * | 2010-04-08 | 2011-10-13 | Hans Otto Meyer zu Spelbrink | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
-
2010
- 2010-04-08 DE DE102010014290A patent/DE102010014290A1/de not_active Ceased
-
2011
- 2011-03-04 PL PL11001816T patent/PL2374461T3/pl unknown
- 2011-03-04 ES ES11001816.5T patent/ES2612584T3/es active Active
- 2011-03-04 DK DK11001816.5T patent/DK2374461T3/en active
- 2011-03-04 EP EP11001816.5A patent/EP2374461B1/fr active Active
- 2011-04-06 WO PCT/EP2011/001704 patent/WO2011124366A1/fr not_active Ceased
- 2011-04-06 RU RU2012147474/15A patent/RU2555765C2/ru active
- 2011-04-06 US US13/639,357 patent/US20130190301A1/en not_active Abandoned
- 2011-04-06 CA CA2795334A patent/CA2795334C/fr active Active
- 2011-04-06 CN CN201180021384.XA patent/CN103153312B/zh not_active Expired - Fee Related
- 2011-04-06 JP JP2013503032A patent/JP6158077B6/ja not_active Expired - Fee Related
-
2014
- 2014-01-29 US US14/167,676 patent/US20140148447A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140148447A1 (en) | 2014-05-29 |
| DK2374461T3 (en) | 2017-02-06 |
| ES2612584T3 (es) | 2017-05-17 |
| CN103153312B (zh) | 2015-07-22 |
| EP2374461B1 (fr) | 2016-10-26 |
| US20130190301A1 (en) | 2013-07-25 |
| JP2013523789A (ja) | 2013-06-17 |
| DE102010014290A1 (de) | 2011-10-13 |
| RU2555765C2 (ru) | 2015-07-10 |
| WO2011124366A1 (fr) | 2011-10-13 |
| CA2795334A1 (fr) | 2011-10-13 |
| JP6158077B6 (ja) | 2018-08-29 |
| JP6158077B2 (ja) | 2017-07-05 |
| CN103153312A (zh) | 2013-06-12 |
| RU2012147474A (ru) | 2014-05-20 |
| CA2795334C (fr) | 2015-06-09 |
| EP2374461A1 (fr) | 2011-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261768B (en) | Devices and methods for tissue treatment | |
| PT2532367T (pt) | Agente farmacêutico para o tratamento e/ou prevenção do cancro | |
| PL2898885T3 (pl) | Pochodne pirolopirymidynowe do zastosowania w leczeniu zakażeń wirusowych | |
| GB201302653D0 (en) | Pharmaceutical compositions and methods of treatment | |
| EP2640316A4 (fr) | Dispositifs de maintien de tissus et procédés d'utilisation | |
| AP3480A (en) | Phosphaplatins and their use for treatment of cancers | |
| EP2387407A4 (fr) | Médicament destiné au traitement de la douleur et de l'inflammation | |
| IL238126A0 (en) | Compositions for the treatment and prevention of obesity | |
| ZA201207957B (en) | Prevention and treatment of gastrointestinal infection in mammals | |
| PL2678307T3 (pl) | Zastosowanie pochodnych poliaminoizoprenylu w leczeniu antybiotykami lub środkami antyseptycznymi | |
| PL2374461T3 (pl) | Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką | |
| LT2640728T (lt) | Nauji monenzino dariniai, skirti pirmuonių sukeltų infekcijų gydymui | |
| PT2531124T (pt) | Dispositivos para o tratamento de lesões cutâneas | |
| IL216717A0 (en) | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES | |
| EP2640468A4 (fr) | Procédé d'administration et de traitement | |
| EP2404611A4 (fr) | Peptide pour le traitement prophylactique ou thérapeutique de tumeurs de la peau, dans les stades initiaux | |
| AU2009900091A0 (en) | Methods of treatment and prophylaxis | |
| AU2010902343A0 (en) | Compositions for Therapy and Methods of Treatment | |
| GB201020304D0 (en) | Treatment and prevention of pain | |
| AU2010905239A0 (en) | Method of treatment and prophylaxis | |
| AU2010900897A0 (en) | Skin cancer prevention and treatment | |
| AU2010904813A0 (en) | Skin cancer prevention and treatment | |
| IL221238A0 (en) | Pharmaceutical compositions and methods for the treatment and prevention of cancer | |
| AU2012902296A0 (en) | Compositions for Therapy and Methods of Treatment | |
| HK1170238A (en) | Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |